Richard A. Heyman insider trades
Open-market stock purchases and sales by Richard A. Heyman, Unknown at Oric Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 21, 2013.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | ORIC Oric Pharmaceuticals, Inc | Sold | $45.2K |
| Oct 1, 2026 | ORIC Oric Pharmaceuticals, Inc | Sold | $41.3K |
| Oct 1, 2026 | ORIC Oric Pharmaceuticals, Inc | Bought (not open market) | — |
| Jul 24, 2026 | ORIC Oric Pharmaceuticals, Inc | Sold | $73.3K |
| Jul 24, 2026 | ORIC Oric Pharmaceuticals, Inc | Bought (not open market) | — |
| Jul 24, 2026 | ORIC Oric Pharmaceuticals, Inc | Sold | $84.1K |
| Jul 6, 2026 | ORIC Oric Pharmaceuticals, Inc | Sold | $3.6K |
| Feb 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $32.2K |
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Jan 20, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $13.5K |
| Jan 20, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $19.4K |
| Jan 16, 2026 | ORIC Oric Pharmaceuticals, Inc | Sold | $42K |
| Jan 16, 2026 | ORIC Oric Pharmaceuticals, Inc | Sold | $38.4K |
| Jan 9, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $107K |
| Jan 8, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $40.5K |
| Jan 8, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $201K |
| Jan 2, 2026 | ORIC Oric Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- ORIC Oric Pharmaceuticals, Inc: 22 sales, last Oct 1, 2026
- ELVN Enliven Therapeutics, Inc: 33 sales, last Feb 17, 2026
- PMVP PMV Pharmaceuticals, Inc: 8 sales, last Jun 5, 2025
- RYZB RayzeBio, Inc: other filings, last Feb 26, 2024
- GRTS Gritstone bio, Inc: other filings, last Jun 17, 2022
- MTCR Metacrine, Inc: other filings, last May 18, 2022
- YMTX Yumanity Therapeutics, Inc: other filings, last Jun 2, 2021
- RCPT Receptos, Inc: other filings, last Aug 27, 2015
- ONVO Organovo Holdings, Inc: other filings, last Aug 20, 2015